An Optimized Method To Differentiate Hl60 Cells Into Neutrophil-Like Cells
Collie, S. P.; Yu, G.; Rypstra, C.; Rawat, S. S.; Parent, C.
Show abstract
The HL60 promyelocytic leukemia cell line is widely used to investigate neutrophil biology due to its genetic tractability and accessibility. HL60 cells can be differentiated into neutrophil-like cells using all-trans retinoic acid (ATRA) or dimethyl sulfoxide (DMSO) treatment. However, these approaches produce cells that lack critical features of mature granulocytes, such as robust chemotaxis with ATRA treatment or multilobed nuclear morphology with DMSO treatment. To overcome these limitations, we developed a sequential differentiation protocol - ATRA for one day followed by DMSO for four days (A1D4) - which yields neutrophil-like cells that more faithfully recapitulate the morphology and functionality of mature human neutrophils. A1D4-differentiated HL60 cells display segmented nuclei with low lamin A/C expression and demonstrate strong chemotactic, oxidative burst, and phagocytic activity. This protocol combines the advantages of individual compounds, producing cells that closely mimic primary neutrophils in both phenotype and function. SUMMARY SENTENCEThe authors provide an improved method to differentiate HL60 cells into neutrophil-like cells that faithfully recapitulates the morphology and functionality of mature human neutrophils.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Choice of lipid supplementation for in vitro erythroid cell culture impacts reticulocyte yield and characteristics 95%
- Comparative Analysis of Methods to Reduce Activation Signature Gene Expression in PBMCs 94%
- Serum-free differentiation platform for the generation of B lymphocytes and natural killer cells from human CD34+ cord blood progenitors 94%
Similar papers in this journal
- Lasting alterations in monocyte and dendritic cell subsets in individuals after hospitalization for COVID-19 95%
- Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression 94%
- Identification of a novel HIF-1α-αMβ2 Integrin-NETosis axis in fibrotic interstitial lung disease 94%
Similar papers in this journal
- Programming megakaryocytes to produce engineered platelets for delivering non-native proteins 94%
- LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model 93%
- An in vitro tumorigenesis model based on live cell-generated oxygen and nutrient gradients 93%
Similar papers in this journal
- Single-cell transcriptomics reveals the identity and regulators of human mast cell progenitors 93%
- Zebrafish Kit ligands cooperate with erythropoietin to promote erythroid cell expansion 93%
- Charge-Altering Releasable Transporters enable specific phenotypic manipulation of resting primary natural killer cells 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.